DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Gamal Esmat
Gamal Esmat
Treatment Program Policy Analysis 2017
Elbasvir and Grazoprevir for Chronic Hepatitis C Genotypes 1 and 4
WGO GUIDANCE for PATIENTS with COVID-19 and LIVER DISEASE
Impact of Different Anti-HCV Regimens on Platelet Count During Treatment in Egyptian Patients Sara Abd El Ghany1, Noha M
Towards HCV Elimination in Egypt by 2020
New Treatment for HCV G4 Towards an End to HCV Epidemic in Egypt
Fibroscan, APRI, FIB4, and GUCI
Progress Report on Access to Hepatitis C Treatment
Ledipasvir/Sofosbuvir with Or Without Ribavirin for 8 Or 12 Weeks For
Excess Mortality Rate Associated with Hepatitis C Virus Infection: a Community-Based Cohort Study in Rural Egypt
Sofosbuvir Plus Ribavirin for Treating Egyptian Patients with Hepatitis C Genotype 4
SVR12 by HCV Genotype
Accelerating Access to Hepatitis C Diagnostics and Treatment
Generic Sofosbuvir/Ledipasvir for Treatment of Naïve, Non-Cirrhotic, Easy to Treat Patients with Chronic Hepatitis C Genotype 4: 8 Vs
Hepatitis C Virus Treatment by Direct-Acting Antivirals In
Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience
WGO Guidance for the Care of Patients with COVID-19 and Liver Disease
Ombitasvir, Paritaprevir, and Ritonavir Plus Ribavirin
Top View
Effectiveness of Ravidasvir Plus Sofosbuvir in Interferon-Naïve and Treated Patients with Chronic Hepatitis C Genotype-4
Brief Resume
Chronic Hepatitis E Virus Infection by Support*K\YPUN[O Froml03 EASL*PU3 Andvukvu ELPA.9LJLU[S` -\Y[OLYPUMVYTH[PVUYLNHYKPUN03* >Yprofs\YX^Y -V
Prof. Gamal Esmat How to Treat HCV in a Resource-Limited Setting the Success Story in Egypt
Effectiveness of Ravidasvir Plus Sofosbuvir in Interferon-Naã¯Ve And
Prof. Gamal Esmat HCV Treatment in the Era of DAA the Egyptian
Ledipasvir/Sofosbuvir with Or Without Ribavirin for 8 Or 12 Weeks For
Ombitasvir, Paritaprevir, and Ritonavir Plus Ribavirin for Chronic Hepatitis C
Generic Daclatasvir Plus Sofosbuvir, with Or Without Ribavirin, in Treatment of Chronic Hepatitis C: Real-World Results from 18 378 Patients in Egypt
WGO Practice Guidelines Style Template
Program Evaluation Screening and Treatment Program to Eliminate Hepatitis C in Egypt 19 Mar 2020
How to Optimize Hepatitis C Virus Treatment Impact on Life Years Saved in Resource-Constrained Countries
Hepatitis C Guideline
HCV AASLD-2015-Lakebreakingabstracts
Real Life Egyptian Experience of Efficacy and Safety of Simeprevir&
Accelerating Access to Hepatitis C Diagnostics and Treatment